These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7506985)

  • 1. Pharmacological modification of glutamate neurotoxicity in vivo.
    Fujisawa H; Dawson D; Browne SE; MacKay KB; Bullock R; McCulloch J
    Brain Res; 1993 Nov; 629(1):73-8. PubMed ID: 7506985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism by NG-nitro-L-arginine of L-glutamate-induced neurotoxicity in cultured neonatal rat cortical neurons. Prolonged application enhances neuroprotective efficacy.
    Vigé X; Carreau A; Scatton B; Nowicki JP
    Neuroscience; 1993 Aug; 55(4):893-901. PubMed ID: 7694182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide synthase inhibition and extracellular glutamate concentration after cerebral ischemia/reperfusion.
    Zhang J; Benveniste H; Klitzman B; Piantadosi CA
    Stroke; 1995 Feb; 26(2):298-304. PubMed ID: 7530389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dizocilpine maleate, MK-801, but not 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline, NBQX, prevents transneuronal degeneration of nigral neurons after neurotoxic striatal-pallidal lesion.
    DeGiorgio LA; DeGiorgio N; Volpe BT
    Neuroscience; 1999 Apr; 90(1):79-85. PubMed ID: 10188935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of various nitric oxide synthase inhibitors on NMDA-induced neuronal injury in rat cortical neurons.
    Wang JY; Chi SI; Wang JY; Hwang CP; Wang JY
    Chin J Physiol; 1996; 39(4):227-33. PubMed ID: 9058007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
    Dawson DA; Graham DI; McCulloch J; Macrae IM
    Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-additive protective effect of dizocilpine and NBQX against neuronal damage.
    Lippert K; Welsch M; Krieglstein J
    Eur J Pharmacol; 1994 Mar; 253(3):207-13. PubMed ID: 7911083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel inhibitor of glutamate release reduces excitotoxic injury in vitro.
    Lustig HS; von Brauchitsch KL; Chan J; Greenberg DA
    Neurosci Lett; 1992 Aug; 143(1-2):229-32. PubMed ID: 1359475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia.
    Buisson A; Margaill I; Callebert J; Plotkine M; Boulu RG
    J Neurochem; 1993 Aug; 61(2):690-6. PubMed ID: 7687658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity.
    Dawson TM; Steiner JP; Dawson VL; Dinerman JL; Uhl GR; Snyder SH
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9808-12. PubMed ID: 7694293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia.
    Adachi K; Kashii S; Masai H; Ueda M; Morizane C; Kaneda K; Kume T; Akaike A; Honda Y
    Graefes Arch Clin Exp Ophthalmol; 1998 Oct; 236(10):766-74. PubMed ID: 9801892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of nitric oxide formation does not prevent glutamate-induced neurotoxicity in neuronal cultures from rat hippocampus.
    Pauwels PJ; Leysen JE
    Neurosci Lett; 1992 Aug; 143(1-2):27-30. PubMed ID: 1279478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic analysis of the mechanism of dark neuron production in cerebral cortex.
    Kherani ZS; Auer RN
    Acta Neuropathol; 2008 Oct; 116(4):447-52. PubMed ID: 18521615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged exposure to hyperbaric oxygen induces neuronal damage in primary rat cortical cultures.
    Huang KL; Wu JN; Lin HC; Mao SP; Kang B; Wan FJ
    Neurosci Lett; 2000 Nov; 293(3):159-62. PubMed ID: 11036185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nitric oxide synthase increases extracellular cerebral glutamate concentration after global ischemia.
    Zhang J; Benveniste H; Piantadosi CA
    Neurosci Lett; 1993 Jul; 157(2):179-82. PubMed ID: 7694195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures.
    Dawson VL; Dawson TM; Uhl GR; Snyder SH
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3256-9. PubMed ID: 8097316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats.
    Suzuki Y; Takagi Y; Nakamura R; Hashimoto K; Umemura K
    Brain Res; 2003 Feb; 964(1):116-20. PubMed ID: 12573519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of mebudipine and dibudipine on cerebral oxygen-glucose deprivation/reperfusion injury.
    Tavakoli-Far B; Rahbar-Roshandel N; Rahimi-Moghaddam P; Mahmoudian M
    Eur J Pharmacol; 2009 May; 610(1-3):12-7. PubMed ID: 19285496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B; Wieloch T
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection from inorganic mercury effects on the in vivo dopamine release by ionotropic glutamate receptor antagonists and nitric oxide synthase inhibitors.
    Vidal L; Durán R; Faro LF; Campos F; Cervantes RC; Alfonso M
    Toxicology; 2007 Sep; 238(2-3):140-6. PubMed ID: 17624650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.